Literature DB >> 4207624

Properties of plasminogen activators formed by neoplastic human cell cultures.

D B Rifkin, J N Loeb, G Moore, E Reich.   

Abstract

A series of human cell lines has been examined for fibrinolysis in culture. The sera that are activating for fibrinolysis by human cells are mouse, monkey, human, horse, and bovine. Individual human sera show considerable variation in the ability to activate fibrinolysis. In common with other neoplastic or transformed mammalian and avian cell cultures, human cell lines of neoplastic origin produce substantial amounts of plasminogen activator. Several cultures of nonmalignant origin also produce plasminogen activator, whereas cultures obtained from trypsinized human embryos, or from human embryonic skin do not. The human melanoma plasminogen activators are of two kinds: a major component with a mol wt of 50,000, and a minor species with a mol wt of approximately 60,000. Both are DFP sensitive, serine proteases.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4207624      PMCID: PMC2139652          DOI: 10.1084/jem.139.5.1317

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Prostatic fibrinolysin; study of a case illustrating role in hemorrhagic diathesis of cancer of the prostate.

Authors:  H J TAGNON; P SCHULMAN; W F WHITMORE; L A LEONE
Journal:  Am J Med       Date:  1953-12       Impact factor: 4.965

2.  Selective lysis of cells transformed by Rous Sarcoma virus.

Authors:  D B Rifkin; E Reich
Journal:  Virology       Date:  1971-07       Impact factor: 3.616

3.  Increased plasminogen activator (urokinase) in tissue culture after fibrin deposition.

Authors:  M B Bernik
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The clinical challenge of disseminated intravascular coagulation.

Authors:  D Deykin
Journal:  N Engl J Med       Date:  1970-09-17       Impact factor: 91.245

Review 6.  Tissue activators of plasminogen.

Authors:  T Astrup
Journal:  Fed Proc       Date:  1966 Jan-Feb

7.  Origin of fibrinolytic activity in cultures of the human kidney.

Authors:  M B Bernik; H C Kwaan
Journal:  J Lab Clin Med       Date:  1967-10

8.  An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses.

Authors:  J C Unkeless; A Tobia; L Ossowski; J P Quigley; D B Rifkin; E Reich
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

9.  Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study.

Authors:  M B Bernik; H C Kwaan
Journal:  J Clin Invest       Date:  1969-09       Impact factor: 14.808

10.  An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammalian fibroblast cultures transformed by DNA and RNA tumor viruses.

Authors:  L Ossowski; J C Unkeless; A Tobia; J P Quigley; D B Rifkin; E Reich
Journal:  J Exp Med       Date:  1973-01-01       Impact factor: 14.307

  10 in total
  41 in total

Review 1.  Secretory function of mononuclear phagocytes: a review.

Authors:  E R Unanue
Journal:  Am J Pathol       Date:  1976-05       Impact factor: 4.307

2.  Fibrinolytic activity associated with cultured human neoplastic and normal cells.

Authors:  K L Rosenthal; W A Tompkins; J T Wachsman
Journal:  Mol Cell Biochem       Date:  1977-04-12       Impact factor: 3.396

3.  Direct fluorescent assay of urokinase and plasminogen activators of normal and malignant cells: kinetics and inhibitor profiles.

Authors:  M Zimmerman; J P Quigley; B Ashe; C Dorn; R Goldfarb; W Troll
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

4.  Immune surveillance and neoplasia--II. A two-stage mathematical model.

Authors:  A Rescigno; C DeLisi
Journal:  Bull Math Biol       Date:  1977       Impact factor: 1.758

5.  Protease effects on specific growth properties of normal and transformed baby hamster kidney cells.

Authors:  M Brown; D Kiehn
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

6.  Release of plasminogen activator from normal and neoplastic endometrium.

Authors:  L Svanberg; B Astedt
Journal:  Experientia       Date:  1979-06-15

7.  Plasminogen activator production accompanies loss of anchorage regulation in transformation of primary rat embryo cells by simian virus 40.

Authors:  R Pollack; R Risser; S Conlon; D Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

8.  Reversible suppression of malignancy and differentiation of melanoma cells.

Authors:  S Silagi
Journal:  Am J Pathol       Date:  1977-12       Impact factor: 4.307

9.  Plasminogen activator induction and platelet aggregation by phorbol and some of its derivatives: correlation with skin irritancy and tumor-promoting activity.

Authors:  P J Brynes; R Schmidt; E Hecker
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

10.  Generation of macrophage migration inhibitory activity by plasminogen activators.

Authors:  R O Roblin; M E Hammond; N D Bensky; A M Dvorak; H F Dvorak; P H Black
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.